Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
134.46
+7.06 (5.54%)
At close: Feb 27, 2026, 4:00 PM EST
134.99
+0.53 (0.39%)
After-hours: Feb 27, 2026, 7:54 PM EST
Illumina Employees
Illumina had 10,080 employees as of December 28, 2025. The number of employees decreased by 290 or -2.80% compared to the previous year.
Employees
10,080
Change (1Y)
-290
Growth (1Y)
-2.80%
Revenue / Employee
$430,853
Profits / Employee
$84,325
Market Cap
20.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 10,080 | -290 | -2.80% |
| Dec 31, 2024 | 10,370 | -2,020 | -16.30% |
| Dec 31, 2023 | 12,390 | -970 | -7.26% |
| Dec 31, 2022 | 13,360 | 1,610 | 13.70% |
| Dec 31, 2021 | 11,750 | 2,400 | 25.67% |
| Dec 31, 2020 | 9,350 | 1,650 | 21.43% |
| Dec 29, 2019 | 7,700 | 400 | 5.48% |
| Dec 30, 2018 | 7,300 | 1,100 | 17.74% |
| Dec 31, 2017 | 6,200 | 700 | 12.73% |
| Dec 31, 2016 | 5,500 | 900 | 19.57% |
| Dec 31, 2015 | 4,600 | 900 | 24.32% |
| Dec 28, 2014 | 3,700 | 700 | 23.33% |
| Dec 29, 2013 | 3,000 | 800 | 36.36% |
| Dec 31, 2012 | 2,200 | -200 | -8.33% |
| Dec 30, 2012 | 2,400 | 300 | 14.29% |
| Dec 31, 2011 | 2,100 | 319 | 17.91% |
| Dec 31, 2010 | 1,781 | 245 | 15.95% |
| Dec 28, 2008 | 1,536 | 495 | 47.55% |
| Dec 30, 2007 | 1,041 | 445 | 74.66% |
| Dec 31, 2006 | 596 | 221 | 58.93% |
| Dec 31, 2005 | 375 | 97 | 34.89% |
| Dec 31, 2004 | 278 | 42 | 17.80% |
| Dec 28, 2003 | 236 | 3 | 1.29% |
| Dec 29, 2002 | 233 | 54 | 30.17% |
| Dec 30, 2001 | 179 | 74 | 70.48% |
| Dec 31, 2000 | 105 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Mettler-Toledo International | 18,100 |
| Agilent Technologies | 18,100 |
| Revvity | 11,000 |
| Waters | 7,900 |
| Exact Sciences | 7,200 |
ILMN News
- 1 day ago - Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida - PRNewsWire
- 2 days ago - Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026 - Business Wire
- 3 days ago - Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics - PRNewsWire
- 4 days ago - Illumina launches TruPath Genome, setting a new standard in genomic insight - PRNewsWire
- 5 days ago - Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - PRNewsWire
- 11 days ago - Illumina To Webcast Upcoming Investor Conference - PRNewsWire
- 12 days ago - Invesco International Growth Fund Q4 2025 Portfolio Update - Seeking Alpha
- 23 days ago - Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript - Seeking Alpha